sb 203580 has been researched along with ganglioside, gd1a in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (ganglioside, gd1a) | Trials (ganglioside, gd1a) | Recent Studies (post-2010) (ganglioside, gd1a) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 321 | 0 | 52 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jou, I; Kim, HY; Park, JY; Park, SM | 1 |
1 other study(ies) available for sb 203580 and ganglioside, gd1a
Article | Year |
---|---|
GM1 induces p38 and microtubule dependent ramification of rat primary microglia in vitro.
Topics: Animals; Blotting, Western; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; G(M1) Ganglioside; Gangliosides; Imidazoles; Interferon-gamma; Lipopolysaccharides; Microglia; Microscopy, Confocal; Microtubules; Nerve Growth Factor; Neurotrophin 3; Nocodazole; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Pyridines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Tubulin Modulators | 2008 |